Adherence to ASCO/CAP HER2 Testing Guidelines: Equivocal Rates and Impact on Management within a Single Institution

被引：0
|
作者：
Portier, B. P.
Downs-Kelly, E.
Lanigan, C.
Cotta, C.
Patil, D.
Procop, G.
Cook, J. R.
Moore, H.
Budd, G. T.
Tubbs, R. R.
机构：
[1] Cleveland Clin, Cleveland, OH USA
[2] Taussig Canc Inst, Cleveland, OH USA
来源：
LABORATORY INVESTIGATION | 2011年 / 91卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1856
引用
收藏
页码：436A / 436A
页数：1
相关论文
共 50 条
  • [41] Impact of 2013 ASCO/CAP HER2 reporting guidelines in breast cancer: An assessment study from Indian oncology centre that primarily performs HER2 IHC testing with special emphasis on IHC equivocal category
    Pasricha, Sunil
    Gupta, Gurudutt
    Garg, Ritu
    Sharma, Anila
    Gandhi, Jatin S.
    Durga, Garima
    Kamboj, Meenakshi
    Grover, Shrruti
    Mehta, Anurag
    BREAST JOURNAL, 2018, 24 (04): : 468 - 472
  • [42] Evaluation of the Impact of the Updated ASCO/CAP 2018 HER2 Guidelines in Invasive Breast Carcinoma
    Mehr, Chelsea
    Collins, Laura
    Quintana, Liza
    LABORATORY INVESTIGATION, 2019, 99
  • [43] Evaluation of the Impact of the Updated ASCO/CAP 2018 HER2 Guidelines in Invasive Breast Carcinoma
    Mehr, Chelsea
    Collins, Laura
    Quintana, Liza
    MODERN PATHOLOGY, 2019, 32
  • [44] Impact of recent 2018 ASCO-CAP HER2 testing guidelines on 2713 breast cancer cases treated according to 2013 ASCO-CAP HER2 guidelines-Western Indian tertiary cancer centre experience
    Pai, Trupti
    Ankolkar, Mandar
    Shetty, Omshree
    Gurav, Mamta
    Dhanavade, Sandeep
    Tambe, Sonali
    Kadam, Vinayak
    Patil, Asawari
    Desai, Sangeeta
    Shet, Tanuja
    MODERN PATHOLOGY, 2019, 32
  • [45] Impact of recent 2018 ASCO-CAP HER2 testing guidelines on 2713 breast cancer cases treated according to 2013 ASCO-CAP HER2 guidelines- Western Indian tertiary cancer centre experience
    Pai, Trupti
    Ankolkar, Mandar
    Shetty, Omshree
    Gurav, Mamta
    Dhanavade, Sandeep
    Tambe, Sonali
    Kadam, Vinayak
    Patil, Asawari
    Desai, Sangeeta
    Shet, Tanuja
    LABORATORY INVESTIGATION, 2019, 99
  • [46] Characteristics of HER2 FISH-Equivocal Breast Cancers and the Impacts on HER2 Status of 2018 ASCO/CAP Guideline
    Kong, Hui
    Bai, Qianming
    Lu, Hongfen
    Zhou, Xiaoyan
    Yang, Wentao
    LABORATORY INVESTIGATION, 2019, 99
  • [47] HER2 FISH classification of equivocal HER2 IHC breast cancers with use of the 2013 ASCO/CAP practice guideline
    Yao-Shan Fan
    Carmen E. Casas
    Jinghong Peng
    Melanie Watkins
    Lynn Fan
    Jennifer Chapman
    Offiong Francis Ikpatt
    Carmen Gomez
    Wei Zhao
    Isildinha M. Reis
    Breast Cancer Research and Treatment, 2016, 155 : 457 - 462
  • [48] HER2 FISH classification of equivocal HER2 IHC breast cancers with use of the 2013 ASCO/CAP practice guideline
    Fan, Yao-Shan
    Casas, Carmen E.
    Peng, Jinghong
    Watkins, Melanie
    Fan, Lynn
    Chapman, Jennifer
    Ikpatt, Offiong Francis
    Gomez, Carmen
    Zhao, Wei
    Reis, Isildinha M.
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 155 (03) : 457 - 462
  • [49] HER2 targeted therapy and outcome in HER2equivocal cases after 2018 ASCO/CAP HER2 guideline modification
    Crespo, James
    Sun, Hongxia
    Wu, Jimin
    Ding, Qingqing
    Tang, Guilin
    Robinson, Melissa
    Chen, Hui
    Sahin, Aysegul A.
    Lim, Bora
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [50] Characteristics of HER2 FISH-Equivocal Breast Cancers and the Impacts on HER2 Status of 2018 ASCO/CAP Guideline
    Kong, Hui
    Bai, Qianming
    Lu, Hongfen
    Zhou, Xiaoyan
    Yang, Wentao
    MODERN PATHOLOGY, 2019, 32
12345